These innovative medications , Tirzepatide , represent a significant advancement in treating metabolic dysfunction and potentially associated ailments . These drugs are categorized as GLP-1 hormone stimulators, meaning they to replicate the endogenous GLP-1 substance , stimulating glucose production and lowering appetite . While Retatrutide every o